<DOC>
	<DOCNO>NCT02624583</DOCNO>
	<brief_summary>Ramadan fasting ( RF ) show associated vascular metabolic disorder include glycemic control lipid profile . It may also alter pharmacologic property medication . Many patient CAD Clopidogrel insist observe fasting take risk alter pharmacologic propriety drug . The aim study assess effect RF clopidogrel resistance patient high cardiovascular risk particular interest patient DM .</brief_summary>
	<brief_title>Effects RF Clopidogrel Resistance Patients High Cardiovascular Risk</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>age 40 year old . least two cardiovascular risk factor accord Framingham classification . patient willing fast ramadan take clopidogrel therapy least six month prior inclusion . patient 40 year . patient unstable diabetes . repeat hypoglycemic episode patient severe uncontrolled hypertension ( high arterial blood pressure 179/109 mmHg despite antihypertensive treatment ) acute coronary syndrome within past year prior enrollment current previous ( 14 day ) use glycoprotein IIb/IIIa severe cardiovascular cerebrovascular disease inability give inform consent baseline platelet count &lt; 100x103/ml current use antidepressant serum creatinine level higher 1.4 mg/dL woman 1.5 mg/dL men hepatic function test least 2.5 time higher normal level terminal disease &lt; 1 year expect mortality</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Fasting</keyword>
	<keyword>Clopidogrel</keyword>
</DOC>